Consortium established to support ICH M7 compliance
An industry work-group comprising of toxicologists, pharmaceutical companies and data experts plans to unveil the early results of a data sharing project...
List view / Grid view
News
Imfinzi wins breakthrough therapy designation
AstraZeneca and MedImmune, have today announced that the US Food and Drug Administration has granted breakthrough therapy designation for Imfinzi for the treatment of patients with locally-advanced, unresectable non-small cell lung cancer...
UK Biobank releases genetic data on 0.5m people
Genetic data on half a million people was made available for research last week by the UK Biobank study. Information about participants’ health and well-being, key body measurements, their diet, occupational history, mental health and activity levels are also included...
The return of the FT Global Pharmaceutical and Biotechnology Conference
The FT Global Pharmaceutical and Biotechnology Conference, now in its 35th successful year, will be returning to London this November...
BIOCAD does its sums for growth
Russian biotech company BIOCAD plans to leverage competitive advantages to take 5% of the European medicines market
FDA launches Supply Chain Security Toolkit for Medical Products
The U.S Food and Drugs Administration (FDA) has led a collaboration to create a Supply Chain Security Toolkit for Medical Products to maximise the available global resources and to deliver quality training and best practices for medical products...
Puration announces strategy to become cannabis market leader
Puration plans to displace pharmaceutical market leader, GW Pharmaceuticals, as part of strategy to grow US cannabis market
Pall Corporation Introduces Proprietary Bioreactor Control System
Pall Corporation, a leader in filtration, separation and purification, is pleased to introduce the mPath™ bioreactor control system to the biopharmaceutical market...
Lonza Pharma&Biotech Launches Ibex™ Solutions – An Innovative New Concept in Biological Manufacturing and Development
Lonza’s commitment to constant innovation and adding value to its customers and partners is today demonstrated by the launch of Ibex™ Solutions – a unique addition to its current offering...
Is extended-release guanfacine effective in children with chronic tic disorders?
A new study has assessed the safety, tolerability, and effectiveness of extended-release guanfacine in children 6-17 years of age who have chronic tic disorders including Tourette's disorder.
New Workflow Is First End-to-End Solution For Extrusion-Based Drug Implant Production
Thermo Scientific Pharma mini implant line is an automated, integrated system designed for continuous production of drug implants...
Multi-million funding for cryo-EM to boost structural biology revolution
US science minister announce new multi-million-pound commitment to boost the burgeoning field of cryo-electron microscopy (cryo-EM) in the UK.
Global research programme to tackle humanitarian crises
£225 million has been invested across 37 interdisciplinary projects to address challenges in fields such as health, humanitarian crises...
C difficile infections market to hit $1.7bn by 2026
GlobalData latest report states that the major drivers of this growth include the projected launch of prophylactic options for the prevention of Clostridium difficile infections...
Patients at risk as UK plans to leave Euratom
The UK's proposed withdrawal from Euratom may threaten the supply of essential medical isotopes, putting cancer patients at risk...
